- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
AllianzGI Wellness Fund
+ Add to WatchlistDGHCX:US
31.70 USD 0.17 0.54%As of 09:29:30 ET on 05/21/2013.
Snapshot for AllianzGI Wellness Fund (DGHCX)
| Year To Date: | +17.36% | 3-Month: | +11.27% | 3-Year: | +17.92% | 52-Week Range: | 23.98 - 32.05 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +1.67% | 1-Year: | +28.05% | 5-Year: | +11.50% | Beta vs MXWO0HC: | 1.08 |
Fund Profile & Information for DGHCX
AllianzGI Wellness Fund is an open-end fund incorporated in the USA. The Fund seeks long-term capital appreciation. The Fund invests at least 65% of its total assets in the equity securities of health care companies of anysize located in at least three different countries, which may include the United States.
| Inception Date: | 12-31-1996 | Telephone: | 1-888-852-3922 |
|---|---|---|---|
| Managers: | KEN TSUBOI / MICHAEL DAUCHOT | ||
| Web Site: | www.allianzinvestors.com | ||
Fundamentals for DGHCX
| NAV | (on 2013-05-21) 31.70 |
|---|---|
| Assets (M) | (on 2013-04-30) 140.60 |
| Fund Leveraged | N |
| Minimum Investment | 1,000.00 |
| Minimum Subsequent Investment | 50.00 |
Dividends for DGHCX
| Dividend Type | Long Term Cap Gain |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | (on 2012-12-13) 2.19 |
| Dividend Yield (ttm) | 6.90 |
Fees & Expenses for DGHCX
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.20 |
| Redemption Fee | 0.00 |
| 12b1 Fee | 0.25 |
| Expense Ratio | 1.46 |
Top Fund Holdings for DGHCX
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Pfizer Inc | 272,525 | 7,922,302 | 5.637% |
| Gilead Sciences Inc | 146,710 | 7,429,394 | 5.286% |
| Vertex Pharmaceuticals Inc | 90,900 | 6,982,938 | 4.968% |
| Merck & Co Inc | 127,745 | 6,004,015 | 4.272% |
| Allergan Inc/United States | 48,900 | 5,552,595 | 3.951% |
| Johnson & Johnson | 49,650 | 4,231,670 | 3.011% |
| Sanofi | 37,305 | 4,033,250 | 2.870% |
| Alexion Pharmaceuticals Inc | 40,000 | 3,920,000 | 2.789% |
| Novo Nordisk A/S | 21,281 | 3,745,981 | 2.665% |
| Roche Holding AG | 14,485 | 3,626,181 | 2.580% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page